共 143 条
[1]
Bolla M(2010)External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study Lancet Oncol 11 1066-1073
[2]
Van Tienhoven G(2009)Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer? Meta-analysis of randomized trials Cancer 115 3446-3456
[3]
Warde P(2005)Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma–long-term results of phase III RTOG 85–31 Int J Radiat Oncol Biol Phys 61 1285-1290
[4]
Dubois JB(2009)Duration of androgen suppression in the treatment of prostate cancer N Engl J Med 360 2516-2527
[5]
Mirimanoff RO(2019)Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial Lancet Oncol 20 267-281
[6]
Storme G(2008)Ten-year follow-up of radiation therapy oncology group protocol 92–02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer J Clin Oncol: Off J Am Soc Clin Oncol 26 2497-2504
[7]
Bria E(2018)Duration of androgen deprivation therapy in high-risk prostate cancer: a randomized phase III trial Eur Urol 74 432-441
[8]
Cuppone F(2009)Impact of the duration of adjuvant hormonal therapy in patients with locally advanced prostate cancer treated with radiotherapy: a secondary analysis of RTOG 85–31 J Clin Oncol: Off J Am Soc Clin Oncol 27 2137-2143
[9]
Giannarelli D(2015)High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial Lancet Oncol 16 320-327
[10]
Milella M(2019)Association of Gleason grade with androgen deprivation therapy duration and survival outcomes: a systematic review and patient-level meta-analysis JAMA Oncol 5 91-96